drugset / Trial / NCT07511361

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

NCT07511361 ↗

Phase 2 Recruiting 140 enrolled Kardigan, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.

Timeline

Start
2026-06-23
Primary completion
2026-12
Completion
2027-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tonlamarsen Unknown — Subcutaneous

Indications